Ariela Samantha

Ariela Samantha

Auto-generated profile, based on publicly available information

Ariela Samantha

Department of General Surgery, Tongji Hospital, School of Medicine Tongji University Shanghai China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2020 in Journal of Molecular Biology
Verified
Journal Article
Closed access
ASAriela Samantha
Ariela Samantha
AVAlice Vrielink
Alice Vrielink

9 January 2023 in Journal of Biological Chemistry
Verified
Journal Article
Open access
HQHeng Qiu
Heng Qiu
CHChristopher Hosking
Christopher Hosking
EREmel Rothzerg
Emel Rothzerg
ASAriela Samantha
Ariela Samantha
KCKai Chen
Kai Chen
Jiake XuJiake Xu
Jiake Xu
Osteoporosis is a chronic skeletal condition characterized by low bone mass and deteriorated microarchitecture of bone tissue and puts tens of millions of people at high risk of fractures. New therapeutic agents like i-bodies, a class of next-generation single-domain antibodies, are needed to overcome some limitations of conventional treatments. An i-body is a human immunoglobulin scaffold with two long binding loops that mimic the shape and position of those found in shark antibodies, the variable new antigen receptors of sharks. Its small size (∼12 kDa) and long binding loops provide access to drug targets, which are considered undruggable by traditional monoclonal antibodies. Here, we have successfully identified a human receptor activator of nuclear factor-κB ligand (RANKL) i-body, ADR3, which demonstrates a high binding affinity to human RANKL (hRANKL) with no adverse effect on the survival or proliferation of bone marrow-derived macrophages. Differential scanning fluorimetry suggested that ADR3 is stable and able to tolerate a wide range of physical environments (including both temperature and pH). In addition, in vitro studies showed a dose-dependent inhibitory effect of ADR3 on osteoclast differentiation, podosome belt formation, and bone resorption activity. Further investigation on the mechanism of action of ADR3 revealed that it can inhibit hRANKL-mediated signaling pathways, supporting the in vitro functional observations. These clues collectively indicate that hRANKL antagonist ADR3 attenuates osteoclast differentiation and bone resorption, with the potential to serve as a novel therapeutic to protect against bone loss.

31 May 2024 in FaST - Jurnal Sains dan Teknologi (Journal of Science and Technology)
Verified
Journal Article
Open access
PDF file
ASAriela Samantha
Ariela Samantha
CSCaitlyn Christvania Sihombing
Caitlyn Christvania Sihombing
AVAlice Vrielink
Alice Vrielink
Antibiotics are often used to fight infections caused by pathogenic bacteria. However, inappropriate use of antibiotics has caused many pathogenic bacteria to gain antibiotic resistance. Some resistance mechanisms arise through enzymatic modification of the bacterial membrane. Lipid A phosphoethanolamine transferase (EptA) modifies bacterial membranes through the addition of phosphoethanolamine to the lipid A moiety of lipopolysaccharide (LPS) or lipooligosaccharide (LOS). Inhibition of EptA would therefore restore the antibiotic susceptibility of the bacterium. In order to develop inhibitors against EptA, in vitro studies are required. Biochemical studies of membrane proteins such as EptA, must be carried out in buffers containing detergent to ensure the solubility and stability of the membrane protein. EptA has been found to be most stable in buffers containing the detergent, n-dodecyl β-D-maltoside (DDM). However, due to the fact that LOS is also required for biochemical studies of EptA, the detergent, sodium deoxycholate (DOC) is also required as it prevents the aggregation of LOS. In this study, the stability and activity of EptA in the presence of DOC were investigated using thin layer chromatography (TLC) and circular dichroism (CD) spectroscopy. Additionally, preliminary studies on the interaction of EptA and LOS in vitro was carried out using native agarose gel electrophoresis (NAGE). This study shows that EptA remains active in the presence of ‰¤ 2 mM DOC with the highest activity observed in buffers containing only 1 mM DOC. CD analysis showed that the overall secondary structure of EptA in buffer containing various concentrations of DDM and DOC was maintained. Additionally, through NAGE analysis the interaction between EptA and LOS was successfully observed. Therefore, further in vitro studies incorporating both substrates with supplementation of up to 1 mM DOC could be carried out with the long-term goal of studying inhibitors against EptA.Bahasa Indonesia Antibiotik sering digunakan untuk melawan infeksi yang disebabkan oleh bakteri patogen. Namun, penggunaan antibiotik yang tidak tepat telah menyebabkan banyak bakteri patogen mendapatkan resistensi antibiotik. Beberapa mekanisme resistensi muncul melalui modifikasi enzimatik dari membran bakteri. Lipid A phosphoethanolamine transferase (EptA) mengubah membran bakteri dengan menambahkan fosfoetanolamina ke bagian lipid A dari lipopolisakarida (LPS) atau lipooligosakarida (LOS). Penghambatan EptA akan mengembalikan kerentanan antibiotik dari bakteri tersebut. Untuk mengembangkan inhibitor terhadap EptA, studi in vitro diperlukan. Studi biokimia protein membran seperti EptA, harus dilakukan dalam larutan penyangga yang mengandung deterjen untuk memastikan kelarutan dan stabilitas protein membran. EptA ditemukan paling stabil dalam larutan penyangga yang mengandung deterjen, n-dodecyl β-D-maltosida (DDM). Namun, karena LOS juga diperlukan untuk studi biokimia EptA, deterjen, sodium deoksikolat (DOC) juga diperlukan karena mencegah agregasi LOS. Dalam penelitian ini, stabilitas dan aktivitas EptA dalam keberadaan DOC diselidiki menggunakan kromatografi lapis tipis (TLC) dan spektroskopi dikroisme sirkular (CD). Selain itu, studi awal tentang interaksi EptA dan LOS in vitro dilakukan menggunakan elektroforesis gel agarosa asli (NAGE). Studi ini menunjukkan bahwa EptA tetap aktif dalam keberadaan ‰¤ 2 mM DOC dengan aktivitas tertinggi diamati dalam larutan penyangga yang hanya mengandung 1 mM DOC. Analisis CD menunjukkan bahwa struktur sekunder keseluruhan EptA dalam larutan penyangga yang mengandung berbagai konsentrasi DDM dan DOC tetap terjaga. Selain itu, melalui analisis NAGE, interaksi antara EptA dan LOS berhasil diamati. Oleh karena itu, studi in vitro lebih lanjut yang memasukkan kedua substrat dengan suplementasi hingga 1 mM DOC bisa dilakukan dengan tujuan jangka panjang untuk mempelajari inhibitor terhadap EptA.

8 November 2026 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
XLXinxing Li
Xinxing Li
XYXin Yang
Xin Yang
LZLin Zhu
Lin Zhu
JWJunyong Weng
Junyong Weng
ZSZezhi Shan
Zezhi Shan
Xinxiang LiXinxiang Li
Xinxiang Li